BriaCell Therapeutics Corp (BCTX)
1.48
+0.09
(+6.47%)
USD |
NASDAQ |
May 20, 16:00
1.57
+0.09
(+6.08%)
After-Hours: 16:31
BriaCell Therapeutics Max Drawdown (5Y): 95.67% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 95.67% |
March 31, 2024 | 95.67% |
February 29, 2024 | 95.67% |
January 31, 2024 | 95.67% |
December 31, 2023 | 95.67% |
November 30, 2023 | 95.67% |
October 31, 2023 | 95.67% |
September 30, 2023 | 95.67% |
August 31, 2023 | 95.67% |
July 31, 2023 | 95.67% |
June 30, 2023 | 95.67% |
May 31, 2023 | 95.67% |
April 30, 2023 | 95.67% |
March 31, 2023 | 95.67% |
February 28, 2023 | 95.67% |
January 31, 2023 | 95.67% |
December 31, 2022 | 95.67% |
November 30, 2022 | 95.67% |
October 31, 2022 | 95.67% |
September 30, 2022 | 95.67% |
August 31, 2022 | 95.67% |
July 31, 2022 | 95.67% |
June 30, 2022 | 95.67% |
May 31, 2022 | 95.67% |
April 30, 2022 | 95.67% |
Date | Value |
---|---|
March 31, 2022 | 95.67% |
February 28, 2022 | 95.67% |
January 31, 2022 | 95.67% |
December 31, 2021 | 95.67% |
November 30, 2021 | 95.67% |
October 31, 2021 | 95.67% |
September 30, 2021 | 95.67% |
August 31, 2021 | 95.67% |
July 31, 2021 | 95.67% |
June 30, 2021 | 95.67% |
May 31, 2021 | 95.67% |
April 30, 2021 | 95.67% |
March 31, 2021 | 95.67% |
February 28, 2021 | 95.67% |
January 31, 2021 | 95.67% |
December 31, 2020 | 95.67% |
November 30, 2020 | 95.67% |
October 31, 2020 | 95.67% |
September 30, 2020 | 94.59% |
August 31, 2020 | 94.59% |
July 31, 2020 | 94.59% |
June 30, 2020 | 94.59% |
May 31, 2020 | 94.59% |
April 30, 2020 | 94.59% |
March 31, 2020 | 94.59% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.59%
Minimum
May 2019
95.67%
Maximum
Oct 2020
95.36%
Average
95.67%
Median
Oct 2020
Max Drawdown (5Y) Benchmarks
CeCors Inc | 98.60% |
Venus Concept Inc | 99.86% |
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -48.35 |
Beta (5Y) | 1.135 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 90.32% |
Historical Sharpe Ratio (5Y) | -0.3954 |
Historical Sortino (5Y) | -0.8137 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.73% |